Comparative Evaluation of Simian, Simian–Human, and Human Immunodeficiency Virus Infections in the Pigtail Macaque ( Macaca nemestrina ) Model
- 1 June 2006
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 22 (6) , 580-588
Abstract
The global impact of HIV/AIDS intensifies the need for a preventive vaccine and nonhuman primate models can help provide critical insights into effective immunity. Pigtail macaques (Macaca nemestrina) are increasingly studied as a nonhuman primate model for AIDS. We compared the virologic and immunologic characteristics of HIV-1, SIV, and SHIV infection of naive pigtail macaques across a series of preclinical HIV vaccine studies. SIVmac251 and SIVmac239 infection of naive pigtail macaques resulted in a gradual decline in peripheral CD4+ T cells in the setting of high levels of viremia, approximating most closely human infection of HIV-1. In contrast, the CXCR4-utilizing SHIVmn229 virus resulted in rapid depletion of CD4+ T cells and minimal generation of humoral or cellular immune responses, similar to that observed with SHIV89.6P infection of rhesus macaques. Infection with the CCR5-utilizing, rhesus macaque passaged, SHIVSF162P3 resulted in some overall CD4+ T cell decline, however, three of eight macaques naturally control SHIVSF162P3 viremia to very low levels in the setting of robust adaptive immunity. Despite attempts at infecting pigtail macaques with HIV-1 strains passaged in juvenile pigtail macaques in vivo or in PBMC isolated from pigtail macaques in vitro, only lower nonsustained levels of viral replication were observed. Our results provide a series of virologic models with which to evaluate potential AIDS vaccines in pigtail macaques.Keywords
This publication has 31 references indexed in Scilit:
- Mucosally-administered human–simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3Vaccine, 2005
- SIV‐specific T lymphocyte responses in PBMC and lymphoid tissues of SIV‐infected pigtailed macaques during suppressive combination antiretroviral therapyJournal of Medical Primatology, 2005
- Analysis of Pigtail Macaque Major Histocompatibility Complex Class I Molecules Presenting Immunodominant Simian Immunodeficiency Virus EpitopesJournal of Virology, 2005
- Efficacy of DNA and Fowlpox Virus Priming/Boosting Vaccines for Simian/Human Immunodeficiency VirusJournal of Virology, 2004
- In Vitro Characterization of a Simian Immunodeficiency Virus-Human Immunodeficiency Virus (HIV) Chimera Expressing HIV Type 1 Reverse Transcriptase To Study Antiviral Resistance in Pigtail MacaquesJournal of Virology, 2004
- Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFN? or IL-12Vaccine, 2004
- Vaccination with Attenuated Simian Immunodeficiency Virus by DNA InoculationJournal of Virology, 2001
- Virus Threshold Determines Disease in SIVsmmPBj14-Infected MacaquesAIDS Research and Human Retroviruses, 1999
- Human Immunodeficiency Virus Type 1 (HIV‐1)‐Specific T Cell Responses Correlate with Control of Acute HIV‐1 Infection in MacaquesThe Journal of Infectious Diseases, 1997
- Infection of Macaca nemestrina by Human Immunodeficiency Virus Type-1Science, 1992